- Home
- TARS vs BSM Comparison
TARS vs BSM Comparison
Compare TARS & BSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- BSM
- Stock Information
- Founded
- TARS 2016
- BSM 1876
- Country
- TARS United States
- BSM United States
- Employees
- TARS N/A
- BSM N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- BSM Oil & Gas Production
- Sector
- TARS Health Care
- BSM Energy
- Exchange
- TARS Nasdaq
- BSM Nasdaq
- Market Cap
- TARS 2.8B
- BSM 2.5B
- IPO Year
- TARS 2020
- BSM 2015
- Fundamental
- Price
- TARS $67.56
- BSM $13.03
- Analyst Decision
- TARS Strong Buy
- BSM Hold
- Analyst Count
- TARS 7
- BSM 1
- Target Price
- TARS $69.43
- BSM $13.00
- AVG Volume (30 Days)
- TARS 613.1K
- BSM 362.2K
- Earning Date
- TARS 11-04-2025
- BSM 11-03-2025
- Dividend Yield
- TARS N/A
- BSM 9.21%
- EPS Growth
- TARS N/A
- BSM N/A
- EPS
- TARS N/A
- BSM 1.16
- Revenue
- TARS $295,521,000.00
- BSM $413,675,000.00
- Revenue This Year
- TARS $139.46
- BSM $4.18
- Revenue Next Year
- TARS $49.91
- BSM $7.84
- P/E Ratio
- TARS N/A
- BSM $11.20
- Revenue Growth
- TARS 254.45
- BSM N/A
- 52 Week Low
- TARS $38.51
- BSM $11.78
- 52 Week High
- TARS $76.81
- BSM $15.66
- Technical
- Relative Strength Index (RSI)
- TARS 54.32
- BSM 54.17
- Support Level
- TARS $65.30
- BSM $12.36
- Resistance Level
- TARS $74.83
- BSM $13.16
- Average True Range (ATR)
- TARS 2.87
- BSM 0.22
- MACD
- TARS -0.99
- BSM 0.02
- Stochastic Oscillator
- TARS 19.64
- BSM 61.74
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About BSM Black Stone Minerals L.P. Common units representing limited partner interests
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.